Bae, W. K., Yoo, K. H., Lee, J. S., Kim, Y., Chung, I., Park, M. H., . . . Hennighausen, L. (2014). The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog.

Bae, Woo Kyun, Kyung Hyun Yoo, Ji Shin Lee, Young Kim, Ik-Joo Chung, Min Ho Park, Jung Han Yoon, Priscilla A. Furth, e Lothar Hennighausen. "The Methyltransferase EZH2 Is Not Required for Mammary Cancer Development, Although High EZH2 and Low H3K27me3 Correlate With Poor Prognosis of ER-positive Breast Cancers." Mol Carcinog 2014.

Bae, Woo Kyun, et al. "The Methyltransferase EZH2 Is Not Required for Mammary Cancer Development, Although High EZH2 and Low H3K27me3 Correlate With Poor Prognosis of ER-positive Breast Cancers." Mol Carcinog 2014.